About: Acorda Therapeutics

Property	Value
dbo:abstract	Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States. (en)
dbo:assets	7.99718E8
dbo:equity	3.1082E8
dbo:foundingYear	1995-01-01 (xsd:gYear)
dbo:industry	dbr:Health_care dbr:Biotechnology
dbo:location	dbr:Ardsley,_New_York
dbo:netIncome	-2.72966E8
dbo:numberOfEmployees	344 (xsd:nonNegativeInteger)
dbo:operatingIncome	-3.11632E8
dbo:product	dbr:4-Aminopyridine dbr:L-DOPA
dbo:revenue	1.92408E8
dbo:thumbnail	wiki-commons:Special:FilePath/Acorda-therapeutics-inc-logo.png?width=300
dbo:type	dbr:Public_company
dbo:wikiPageExternalLink	http://www.acorda.com/ http://topics.nytimes.com/top/news/business/companies/acorda-therapeutics-inc/index.html http://www.hoovers.com/global/cobrands/nasdaq/factsheet.xhtml%3FID=121830
dbo:wikiPageID	25922191 (xsd:integer)
dbo:wikiPageLength	17214 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1113023477 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Carbidopa/levodopa dbr:Catalent dbc:1995_establishments_in_New_York_(state) dbr:Biotie_Therapies dbr:Hoover's dbr:Public_company dbc:Biotechnology_companies_of_the_United_States dbc:Companies_listed_on_the_Nasdaq dbr:Columbia_University_Medical_Center dbr:Chief_executive_officer dbr:Chief_financial_officer dbr:Chief_medical_officer dbr:Chief_operating_officer dbr:General_counsel dbr:Generic_drug dbr:Multiple_sclerosis dbr:The_New_York_Times dbr:Board_of_directors dbr:Stroke dbr:Zolmitriptan dbr:Élan dbc:Companies_based_in_Westchester_County,_New_York dbr:Adenosine_A2A_receptor dbr:Agranulocytosis dbr:Tizanidine dbr:4-Aminopyridine dbr:Food_and_Drug_Administration dbr:Parkinson's_disease dbr:Capsule_(pharmacy) dbr:Primary_sclerosing_cholangitis dbr:President_(corporate_title) dbr:Profit_(economics) dbr:Hawthorne,_New_York dbr:Health_care dbr:Ardsley,_New_York dbc:Health_care_companies_based_in_New_York_(state) dbc:Life_sciences_industry dbc:Pharmaceutical_companies_of_the_United_States dbc:Biotechnology_companies_established_in_1995 dbr:Chief_scientific_officer dbr:L-DOPA dbr:Biotechnology dbr:Tablet_(pharmacy) dbr:Business_model dbr:Spasticity dbr:Spinal_cord_injury dbr:Initial_public_offering dbr:Migraine dbr:Neurologist dbr:Canadian_Spinal_Research_Organization dbr:Cash_flow dbr:CVT-301 dbr:Primary_Sclerosing_Cholangitis dbr:Internist dbr:Patent_protection
dbp:assets	(en) 7.99718E8
dbp:equity	(en) 3.1082E8
dbp:founder	Ron Cohen (en)
dbp:industry	dbr:Health_care dbr:Biotechnology (en)
dbp:keyPeople	Ron Cohen (en)
dbp:location	420 (xsd:integer)
dbp:locationCountry	U.S. (en)
dbp:logo	Acorda-therapeutics-inc-logo.PNG (en)
dbp:name	Acorda Therapeutics, Inc. (en)
dbp:netIncome	(en) -2.72966E8
dbp:numEmployees	344 (xsd:integer)
dbp:operatingIncome	(en) -3.11632E8
dbp:products	dbr:4-Aminopyridine dbr:L-DOPA (en)
dbp:revenue	(en) 1.92408E8
dbp:tradedAs	NASDAQ:ACOR (en)
dbp:type	dbr:Public_company
dbp:wikiPageUsesTemplate	dbt:As_of dbt:Authority_control dbt:Decrease dbt:Infobox_company dbt:Portal dbt:Reflist dbt:Short_description dbt:Start_date_and_age dbt:Url dbt:Negative_increase dbt:Pharmaceutical_companies_of_the_United_States
dcterms:subject	dbc:1995_establishments_in_New_York_(state) dbc:Biotechnology_companies_of_the_United_States dbc:Companies_listed_on_the_Nasdaq dbc:Companies_based_in_Westchester_County,_New_York dbc:Health_care_companies_based_in_New_York_(state) dbc:Life_sciences_industry dbc:Pharmaceutical_companies_of_the_United_States dbc:Biotechnology_companies_established_in_1995
gold:hypernym	dbr:Company
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:WikicatCompaniesBasedInNewYork yago:WikicatCompaniesEstablishedIn1995 yago:WikicatCompaniesInTheNASDAQBiotechnologyIndex yago:WikicatCompaniesListedOnNASDAQ yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesOfTheUnitedStates
rdfs:comment	Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States. (en)
rdfs:label	Acorda Therapeutics (en)
owl:sameAs	freebase:Acorda Therapeutics yago-res:Acorda Therapeutics wikidata:Acorda Therapeutics dbpedia-fa:Acorda Therapeutics dbpedia-fi:Acorda Therapeutics https://global.dbpedia.org/id/4LCLT
skos:closeMatch	http://www.grid.ac/institutes/grid.417402.4
prov:wasDerivedFrom	wikipedia-en:Acorda_Therapeutics?oldid=1113023477&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Acorda-therapeutics-inc-logo.png
foaf:isPrimaryTopicOf	wikipedia-en:Acorda_Therapeutics
foaf:name	Acorda Therapeutics, Inc. (en)
is dbo:wikiPageRedirects of	dbr:Civitas_Therapeutics dbr:Acorda_Therapeutics,_Inc.
is dbo:wikiPageWikiLink of	dbr:Biogen dbr:Biotie_Therapies dbr:PatientsLikeMe dbr:List_of_pharmaceutical_companies dbr:Third_Point_Management dbr:Leerom_Segal dbr:Fred_D._Lublin dbr:Civitas_Therapeutics dbr:4-Aminopyridine dbr:Aaron_E._Miller dbr:L-DOPA dbr:Interferon_beta-1a dbr:Canadian_Spinal_Research_Organization dbr:List_of_drugs:_Tj–Tq dbr:Acorda_Therapeutics,_Inc.
is foaf:primaryTopic of	wikipedia-en:Acorda_Therapeutics